Wheelchair Positioning and Neuromuscular Diseases
BDD-POSIT-MNM
1 other identifier
observational
50
1 country
2
Brief Summary
This database will describe sitting postural control in wheelchair, as well as PW pain, and pressure ulcers associated with sitting, in patients with neuromuscular disease (NMD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2021
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 17, 2021
CompletedFirst Submitted
Initial submission to the registry
August 11, 2021
CompletedFirst Posted
Study publicly available on registry
August 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMarch 11, 2025
March 1, 2025
4.5 years
August 11, 2021
March 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Description of postural wheelchair disorders in the neuromuscular disease population
Measurement of Posture by the tool: Measurement of Postural Control in Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0) score (0 = normal, 1 = mild, 2 = moderated and 3 = severe)
At the beginning and the end of the study, an average of 6 months
Secondary Outcomes (4)
Comparison of pain associated with using the wheelchair
At the beginning and the end of the study (before positioning equipment and few months after use), an average of 6 months
Assessment of the incidence of pressure ulcers associated with sitting in NMD
At the beginning and the end of the study (before positioning equipment and few months after use), an average of 6 months
Assessment of the proportion of technical postural aids prescribed for patients who accept the positioning equipment
At the end of the study, an average of 6 months
Assessment of the technical postural aids efficacy
At the beginning and the end of the study (before positioning equipment and few months after use), an average of 6 months
Interventions
Assessment of postural wheelchair disorders, as well as PW pain, and pressure ulcers associated with sitting
Eligibility Criteria
Patients with neuromuscular disease, using Wheelchair, seen in positioning consultation by N. Pellegrini and / or E. Dupitier
You may qualify if:
- Patient with neuromuscular disease
- Written informed consent (IC) obtained
- Adult patients (\> 18 years) Or
- Adults under guardianship who has given theirs oral consent and guardian's consent obtained Or
- Childs who has given theirs oral consent and parents' consent obtained
- Wheelchair user
You may not qualify if:
- Patient not seen in positioning consultation by N. Pellegrini and / or E. Dupitierr
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Groupement Hospitalier Intercommunal du Vexin / Site d'Aincourt - Pôle Soins de Suite et de Réadaptation spécialisés
Aincourt, 95510, France
Clinique du Positionnement de l'AFM
Évry, 91 000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nadine Pellegrini
Groupement Hospitalier Intercommunal du Vexin
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2021
First Posted
August 16, 2021
Study Start
May 17, 2021
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
March 11, 2025
Record last verified: 2025-03